ILMN
$273.68+0.62%
as of close, Sep 30, 2026
☾ AH $273.68 +0.62%
Illumina Inc.Stock · Health CareNasdaq Composite 0.05%Russell 1000 0.04%Russell 3000 0.04%US Stock Market 0.03%MSCI ACWI 0.03%MSCI World 0.03%S&P 500
ILMN — Illumina Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
100.0150.0200.0250.0300.0350.0400.0450.0020.0M40.0M$273.68—20162019202120242026
2026-09-30
Price$273.68
MA20$186.17
MA50$145.21
Vol16.7M
Key stats
Price data
- Price
- $273.68
- Change YTD
- +108.66%
- Next earnings
- Oct 29, 2026
- Market cap
- 41.3B
- Enterprise value
- 40.7B
- Shares outstanding
- 151M
- 52W low
- $88.00
- 52W high
- $280.17
- From 52W high
- -2.31%
- From 52W low
- +211.00%
- 52W range
- 97%
- Beta
- 1.45
Volume
- Rel volume
- 0.86×
- 30D volume
- 3.4M
- 30D $ vol
- 807.2M
Fundamentals
- Sales (ttm)
- 4.5B
- Sales/share
- $29.75
- EPS (ttm)
- $5.37
- FCF (ttm)
- 931M
- FCF/share
- $6.17
- Book value/share
- $18.79
- Net margin
- 18.36%
- ROE
- 29.07%
- ROA
- 12.41%
- Current ratio
- 1.80
Growth (CAGR, ttm) · 10Y
- Sales
- +4.90%+0.24%+2.54%+6.87%
- Net income
- -34.46%n/a+1.45%+6.68%
- FCF
- -9.73%n/a+0.73%+2.86%
- Shares
- -1.76%-1.57%+0.58%+0.30%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -32.21%n/a+0.64%+6.34%
- Sales/share
- +6.78%+1.83%+1.94%+6.56%
- FCF/share
- -8.11%n/a+0.14%+2.55%
- Book value/share
- +28.04%-23.22%-11.89%+2.98%
- Price
- +188.38%+26.99%-7.06%+4.77%
- Total return
- +188.38%+26.99%-7.06%+4.77%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 50.9×
- P/OI (ttm)
- 46.9×
- Fwd P/E
- 44.3×
- P/S (ttm)
- 9.2×
- P/B (mrq)
- 14.6×
- P/FCF (ttm)
- 44.4×
- EV/EBITDA (fy)
- 35.3×
- EV/Sales (ttm)
- 9.1×
- FCF yield (ttm)
- 2.25%
- Buyback yield (realized, 1y)
- 1.76%
- Shareholder yield (realized, 1y)
- 1.76%
- Buyback yield (cash, ttm)
- 1.21%
- Shareholder yield (cash, ttm)
- 1.21%
Vs own 10Y history
- P/E
- 51st
- P/OI
- 38th
- P/S
- 47th
- P/B
- 98th
- P/FCF
- 27th
Bar = where today’s multiple sits in ILMN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-09-30
1D
+0.62%
5D
+7.17%
1M
+26.94%
3M
+55.65%
YTD
+108.66%
1Y
+188.18%
5Y
-30.64%
Financial statements
Open full ILMN financials →Loading financial statements…
Related Health Care
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -7.31% | -2.15% |
| NVO | Novo Nordisk A/S | -16.88% | -1.04% |
| SNY | Sanofi ADS | -8.01% | +1.20% |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | -5.21% | -2.39% |
| NTRA | Natera Inc. | +26.68% | -0.29% |
| ARGX | argenx SE American Depositary Shares | -6.28% | -1.21% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | +0.89% | -1.73% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +8.67% | -0.53% |
